• Akshay Madan, Sandeep K Ganji, Zhongxu An, Kevin S Choe, Marco C Pinho, Robert M Bachoo, Elizabeth M Maher, and Changho Choi.
• Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
• Magn Reson Med. 2015 Jun 1; 73 (6): 2094-9.

PurposeTo evaluate the T2 relaxation time of lactate (Lac) in brain tumors and the correlation of the T2 and concentration with tumor grades.MethodsEight pairs of the subecho time sets of point-resolved spectroscopy were selected between 58 and 268 ms, with numerical and phantom analyses, for Lac T2 measurement. In vivo spectra were acquired from 24 subjects with gliomas (13 low grade and 11 high grade) and analyzed with LCModel using numerically-calculated basis spectra. The metabolite T2 relaxation time was obtained from monoexponential fitting of the multi-echo time (TE) signal estimates versus TE. The metabolite concentration was estimated from the zero-TE extrapolation of the T2 fits.ResultsThe Lac T2 was estimated to be approximately 240 ms, without a significant difference between low and high grade tumors. The Lac concentration was estimated to be 4.1 ± 3.4 and 7.0 ± 4.7 mM for low and high grades respectively, but the difference was not significant.ConclusionThe Lac T2 was similar among gliomas regardless of their tumor grades. This suggests that the T2 value from this study may be applicable to obtain the T2 relaxation-free estimates of Lac in a subset of brain tumors.© 2014 Wiley Periodicals, Inc.

30 keywords...

hide…